Chu De Quebec-universite Laval

This phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Rese…

This study looks at whether a special PET/CT scan (called 18F-DCFPyL) can find cancer spread that standard scans miss in men with castration-resistant prostate cancer starting enzalutamide. Fifty men whose standard scans showed no or few metastases will get the new scan. The goal…

This study is looking at how things like diet, physical activity, and other lifestyle habits might affect a man's risk of getting prostate cancer. Researchers are studying more than 2000 men who are at higher risk to find biological markers in the blood that could help predict ri…